Literature DB >> 21337554

Clinical outcomes of the KYOCERA Physio Hinge Total Knee System Type III after the resection of a bone and soft tissue tumor of the distal part of the femur.

Akihiko Matsumine1, Takafumi Ueda, Takashi Sugita, Yasuo Yazawa, Kazuo Isu, Akira Kawai, Satoshi Abe, Toshitake Yakushiji, Hiroaki Hiraga, Akihiro Sudo, Atsumasa Uchida.   

Abstract

BACKGROUND AND OBJECTIVES: The KYOCERA Physio Hinge Total Knee System Type III (PHKIII) was developed to reconstruct bony defects of the distal femur. The PHKIII is originative in that the metallic parts are fully made of titanium alloy, and this prosthesis has a unique semi-rotating hinge joint and was designed especially for people with the Asian physical body-type. The clinical outcomes of the PHKIII after the resection of musculoskeletal tumors of the distal femur were evaluated.
METHODS: There were 41 males and 28 females with a median age of 48-years. The median duration of follow-up was 57 months.
RESULTS: Eleven early complications and 37 late complications were observed, including 10 recurrences, 7 deep infections, 7 aseptic loosenings, 4 stem breakages, 4 displacements of shaft cap, and one wear of rotation sleeve. Twenty four prosthesis (35%) required a secondary operation because of complications. The five-year overall prosthetic survival rates, -prosthetic survival rate without aseptic loosening, and -limbs preservation rate were 85%, 90%, and 86%, respectively. The mean functional score according to the classification system of the Musculoskeletal Tumor Society was 20.5 points (68%).
CONCLUSIONS: Although continuous follow-up is required, reconstructions using PHKIII are considered to achieve more acceptable functional results.
Copyright © 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21337554     DOI: 10.1002/jso.21823

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  6 in total

1.  Clinical outcomes of Kyocera Modular Limb Salvage system after resection of bone sarcoma of the distal part of the femur: the Japanese Musculoskeletal Oncology Group study.

Authors:  Tomoki Nakamura; Akihiko Matsumine; Atsumasa Uchida; Akira Kawai; Yoshihiro Nishida; Toshiyuki Kunisada; Nobuhito Araki; Hideshi Sugiura; Masato Tomita; Masahiro Yokouchi; Takafumi Ueda; Akihiro Sudo
Journal:  Int Orthop       Date:  2013-10-26       Impact factor: 3.075

2.  Short-term clinical outcomes of Kyocera Modular Limb Salvage System designed cementless stems for the endoprosthetic reconstruction of lower extremities: a Japanese Musculoskeletal Oncology Group multi-institutional study.

Authors:  Satoshi Tsukushi; Yoshihiro Nishida; Takeshi Hirose; Eiji Nakata; Rumi Nakagawa; Tomoki Nakamura; Jungo Imanishi; Akihito Nagano; Hironari Tamiya; Takafumi Ueda
Journal:  BMC Cancer       Date:  2022-07-16       Impact factor: 4.638

3.  Application and Development of Megaprostheses in Limb Salvage for Bone Tumors Around the Knee Joint.

Authors:  Hao-Ran Zhang
Journal:  Cancer Control       Date:  2022 Jan-Dec       Impact factor: 2.339

4.  Compress knee arthroplasty has 80% 10-year survivorship and novel forms of bone failure.

Authors:  John H Healey; Carol D Morris; Edward A Athanasian; Patrick J Boland
Journal:  Clin Orthop Relat Res       Date:  2013-03       Impact factor: 4.176

5.  Establishment and validation of a nomogram model for aseptic loosening after tumor prosthetic replacement around the knee: a retrospective analysis.

Authors:  Hao-Ran Zhang; Feng Wang; Xiong-Gang Yang; Ming-You Xu; Rui-Qi Qiao; Ji-Kai Li; Yun-Long Zhao; Cheng-Gang Pang; Xiu-Chun Yu; Yong-Cheng Hu
Journal:  J Orthop Surg Res       Date:  2019-11-09       Impact factor: 2.359

6.  Long-Term Results of Kyocera Modular Limb Salvage System after Resection of Tumors in the Distal Part of the Femur: Report from Japanese Musculoskeletal Oncology Group Study.

Authors:  Tomoki Nakamura; Akihiko Matsumine; Yu Toda; Satoshi Takenaka; Hidetatsu Outani; Tomohiro Fujiwara; Yoshihiro Nishida; Satoshi Tsukushi; Yasunori Tome; Teruya Kawamoto; Munehisa Kito; Naohiro Shinohara; Masato Tomita; Tomoaki Torigoe; Akihiro Sudo; Hirotaka Kawano
Journal:  Cancers (Basel)       Date:  2022-02-10       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.